C-Reactive Protein Polyclonal Antibody, Invitrogen
C-Reactive Protein Antibody, PA1-18303, from Invitrogen. Species Reactivity: Human; Applications: Western Blot.
Manufacturer: Invitrogen PA118303
C-Reactive Protein Antibody, PA1-18303, from Invitrogen. Species Reactivity: Human; Applications: Western Blot.C Reactive Protein is a major acute phase reactant synthesized primarily in the liver hepatocytes. It is a pentraxin (cyclic pentameric protein) compound of five identical nonglycosylated subunits of 206 amino acids each (m.w. 24 kDa), that are bound noncovalently to form the physiologic CRP molecule (m.w. 117.5 kDa). C Reactive Protein mediates activities associated with preimmune nonspecific host resistance. It is opsonic, an initiator of the classical complement cascade and an activator of monocytes/macrophages. CRP also binds to several nuclear components including chromatin, histones and snRNP, suggesting that it may play a role as a scavenger during cell necrosis.
Host Species: Goat
Cross Reactivity: Human
Immunogen: Recombinant human C-Reactive protein.
Formulation: 100µL unpurified antibody in whole serum and no preservative
Synonyms: CRP, PTX1
Uniprot Accession: P02741
Entrez GeneID: 1401
Gene Symbol: CRP
PA1-18303 detects C-reactive protein from human samples. PA1-18303 has been successfully used in Western blot procedures. The PA1-18303 immunogen is recombinant human C-Reactive protein. Reconstitute with 100 ul of distilled water.
|Recombinant human C-Reactive protein.|
|Avoid Freeze/Thaw Cycles|
|100μL unpurified antibody in whole serum and no preservative|
Purchase any three Invitrogen™ Antibodies and receive a fourth antibody at no additional cost. This is an NLSU exclusive offer. You must apply and qualify for the program to be eligible.
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok